Ling Deng

749 total citations
26 papers, 555 citations indexed

About

Ling Deng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ling Deng has authored 26 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Ling Deng's work include RNA modifications and cancer (7 papers), RNA Research and Splicing (7 papers) and Ubiquitin and proteasome pathways (6 papers). Ling Deng is often cited by papers focused on RNA modifications and cancer (7 papers), RNA Research and Splicing (7 papers) and Ubiquitin and proteasome pathways (6 papers). Ling Deng collaborates with scholars based in China, Laos and United States. Ling Deng's co-authors include Shiwu Dong, Dajun Ying, Yufei Wang, Zhensheng Li, Weijun Chen, Hongfeng Guo, Da‐Qiang Li, Shu‐Yuan Hu, Li Liao and Yinling Zhang and has published in prestigious journals such as Cancer Research, International Journal of Molecular Sciences and Science Advances.

In The Last Decade

Ling Deng

26 papers receiving 551 citations

Peers

Ling Deng
Joana Vieira de Castro Portugal
Shan Zong China
Ziyin Zhao China
Ming Zhu China
Anna Brichkina Germany
Yanzheng Gao China
Yang Tan China
Amna Sajjad Pakistan
Zuochong Yu China
Joana Vieira de Castro Portugal
Ling Deng
Citations per year, relative to Ling Deng Ling Deng (= 1×) peers Joana Vieira de Castro

Countries citing papers authored by Ling Deng

Since Specialization
Citations

This map shows the geographic impact of Ling Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Deng more than expected).

Fields of papers citing papers by Ling Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Deng. The network helps show where Ling Deng may publish in the future.

Co-authorship network of co-authors of Ling Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Deng. A scholar is included among the top collaborators of Ling Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Deng. Ling Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Deng, Ling, Li Liao, Shu‐Yuan Hu, et al.. (2024). SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1. Science Advances. 10(14). eadj4009–eadj4009. 28 indexed citations
3.
Chen, Siyu, Yinling Zhang, Li Liao, et al.. (2024). Spermatid perinuclear RNA-binding protein promotes UBR5-mediated proteolysis of Dicer to accelerate triple-negative breast cancer progression. Cancer Letters. 586. 216672–216672. 2 indexed citations
4.
5.
Wang, Xueqin, Laifa Wang, Ling Deng, et al.. (2023). Dna Hypomethylation And Upregulated LINC00518 Acts As A Promoter And Biomarker In Head And Neck Squamous Cell Carcinoma. Epigenomics. 15(5). 293–306. 2 indexed citations
6.
Liao, Li, et al.. (2023). C9orf142 transcriptionally activates MTBP to drive progression and resistance to CDK4/6 inhibitor in triple‐negative breast cancer. Clinical and Translational Medicine. 13(11). e1480–e1480. 3 indexed citations
7.
Zhang, Fanglin, Li Liao, Yinling Zhang, et al.. (2023). Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancer. Theranostics. 13(3). 973–990. 24 indexed citations
8.
Deng, Ling, Li Liao, Yinling Zhang, et al.. (2023). MYC-driven U2SURP regulates alternative splicing of SAT1 to promote triple-negative breast cancer progression. Cancer Letters. 560. 216124–216124. 19 indexed citations
9.
Liao, Li, Shu‐Yuan Hu, Ling Deng, et al.. (2023). ETHE1 Accelerates Triple-Negative Breast Cancer Metastasis by Activating GCN2/eIF2α/ATF4 Signaling. International Journal of Molecular Sciences. 24(19). 14566–14566. 5 indexed citations
10.
11.
Liao, Li, Ling Deng, Xiao-Yan Ma, et al.. (2022). Protein Phosphatase 1 Subunit PPP1R14B Stabilizes STMN1 to Promote Progression and Paclitaxel Resistance in Triple-Negative Breast Cancer. Cancer Research. 83(3). 471–484. 43 indexed citations
12.
13.
Lu, Xiaoxue, Yanan Tong, Zhujun Zhang, et al.. (2022). Long non-coding RNA EVADR induced by Fusobacterium nucleatum infection promotes colorectal cancer metastasis. Cell Reports. 40(3). 111127–111127. 51 indexed citations
14.
Zhang, Yinling, Ye Zhang, Li Liao, et al.. (2022). RNF144A exerts tumor suppressor function in breast cancer through targeting YY1 for proteasomal degradation to downregulate GMFG expression. Medical Oncology. 39(4). 48–48. 9 indexed citations
15.
Gao, Ziyun, et al.. (2022). CUX2 prevents the malignant progression of gliomas by enhancing ADCY1 transcription. Experimental Brain Research. 240(12). 3153–3165. 2 indexed citations
16.
Deng, Ling, et al.. (2022). Daurisoline Inhibiting Tumor Angiogenesis and Epithelial-Mesenchymal Transition in Bladder Cancer by Mediating HAKAI Protein Stability. Iranian journal of pharmaceutical research. 21(1). e129798–e129798. 8 indexed citations
17.
Wang, Qinjun, et al.. (2021). Hsa_circ_0074032 promotes prostate cancer progression through elevating homeobox A1 expression by serving as a microRNA‐198 decoy. Andrologia. 54(1). e14312–e14312. 5 indexed citations
18.
Deng, Ling, et al.. (2016). Basis expansion model for channel estimation in LTE-R communication system. Digital Communications and Networks. 2(2). 92–96. 9 indexed citations
19.
Fu, Shu Man, et al.. (2015). Induction function of siRNA-mediated survivin gene silencing on nasopharyngeal carcinoma cell apoptosis. Genetics and Molecular Research. 14(1). 2537–2545. 1 indexed citations
20.
Guo, Hongfeng, Zhensheng Li, Shiwu Dong, et al.. (2012). Piezoelectric PU/PVDF electrospun scaffolds for wound healing applications. Colloids and Surfaces B Biointerfaces. 96. 29–36. 218 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joana Vieira de Castro Breakdown of academic impact, for papers by Shan Zong Breakdown of academic impact, for papers by Ziyin Zhao Breakdown of academic impact, for papers by Ming Zhu Breakdown of academic impact, for papers by Anna Brichkina Breakdown of academic impact, for papers by Yanzheng Gao Breakdown of academic impact, for papers by Yang Tan Breakdown of academic impact, for papers by Amna Sajjad Breakdown of academic impact, for papers by Zuochong Yu
Rankless by CCL
2026